Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 20 jun 2018 - 07:00
  • Statutory name argenx SE
  • Title argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris

Related downloads

201806200000000003_argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris.pdf

Date last update: 19 November 2018

Share information

Share on: Share this